REGENERON PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 896.8 USD | +0.32% |
|
-0.87% | +2.11% |
| Apr. 17 | UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating | MT |
| Apr. 17 | The market is pinning its hopes on earnings reports |  |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-16 | 2024-04-17 | 2024-04-18 | 2024-04-19 | |
|---|---|---|---|---|
| Last | 894.14 $ | 901.19 $ | 893.99 $ | 896.82 $ |
| Volume | 615 756 | 468 668 | 450 630 | 507 466 |
| Change | -0.49% | +0.79% | -0.80% | +0.32% |
| Opening | 897.22 | 903.88 | 901.26 | 913.97 |
| High | 901.07 | 911.64 | 908.81 | 920.73 |
| Low | 890.43 | 899.90 | 891.67 | 891.46 |
Performance
| 1 day | +0.32% | ||
| 1 week | -0.87% | ||
| Current month | -6.82% | ||
| 1 month | -6.94% | ||
| 3 months | -3.92% | ||
| 6 months | +10.90% | ||
| Current year | +2.11% | ||
| 1 year | +10.87% | ||
| 3 years | +79.48% | ||
| 5 years | +169.04% | ||
| 10 years | +202.22% |
Volumes
marketsDaily volume
507 466
Estimated daily volume
507 466
Avg. Volume 20 sessions
463 355
Daily volume ratio
1.10
Avg. Volume 20 sessions USD
415 546 031.10
Record volume 1
28 282 394
Record volume 2
15 385 360
Record volume 3
13 646 090
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
96 069 860 405
Net sales (USD)
13 117 200 000
Number of employees
13 450
Sales / Employee (USD)
975 257
Free-Float
77.74 %
Free-Float capitalization (USD)
94 008 870 163
Average Daily Capital Traded
0.43%
Highs and lows
1 week
890.43
921.12
1 month
890.43979.26
Current year
871.39998.33
1 year
684.81998.33
3 years
478.40998.33
5 years
271.37998.33
10 years
269.50998.33
Indicators
Moving average 5 days
896.94
Moving average 20 days
938.74
Moving average 50 days
953.65
Moving average 100 days
921.40
Price spread / (MMA5)
+0.01%
Price spread / (MMA20)
+4.67%
Price spread / (MMA50)
+6.34%
Price spread / (MMA100)
+2.74%
STIM
RSI 9 days
23.16
RSI 14 days
27.93
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.32% | -0.87% | +2.11% | +10.87% | 96.07B | ||
| +0.20% | -0.57% | -3.10% | +20.04% | 102B | ||
| -1.37% | -4.31% | -1.80% | -2.15% | 21.66B | ||
| +0.74% | +0.38% | -17.75% | -28.72% | 20.77B | ||
| +0.58% | -2.95% | -6.91% | -27.61% | 18.53B | ||
| -2.83% | -1.61% | -42.00% | -46.82% | 16.91B | ||
| -1.85% | -8.34% | -28.19% | -49.90% | 13.79B | ||
| -0.41% | -1.98% | +0.18% | +25.87% | 13.33B | ||
| -0.80% | -5.90% | +19.90% | -6.85% | 10.94B | ||
| -1.97% | -12.72% | -23.23% | -26.10% | 8.57B | ||
| -0.51% | -4.02% | +11.29% | +68.82% | 8.05B | ||
| +0.17% | +0.86% | -0.45% | +58.39% | 7.65B | ||
| -1.93% | -7.58% | +240.78% | +198.17% | 7.13B | ||
| -4.68% | -9.21% | -57.36% | -76.43% | 7.05B | ||
| +0.82% | -5.60% | -19.09% | +78.09% | 7.02B | ||
| +0.13% | -1.27% | -6.13% | +17.54% | 6.63B | ||
| Average | -0.89% | -4.04% | +4.27% | +13.33% | ||
| Weighted average by Cap. | -0.49% | -2.19% | -1.37% | +8.30% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
ad531a0f21a8a076f32679757f9d5.nOAuqJXp_-ofVOreBu0Ep1RDU-QLneJ3fSYXaO4V4kY.1NN37tPQlttxbd-TMLRU8RUlFLNR_qMOBxN1W913gR_wiUCYxr-3vFAFhQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 896.8 | 105,156 | 283,680 |
| 03:59:59 pm | 896.8 | 200 | 178,524 |
| 03:59:59 pm | 896.8 | 100 | 178,324 |
| 03:59:59 pm | 897 | 300 | 178,224 |
| 03:59:59 pm | 896.8 | 200 | 177,924 |
| 03:59:59 pm | 896.8 | 200 | 177,724 |
| 03:59:58 pm | 896.8 | 188 | 177,524 |
| 03:59:58 pm | 896.8 | 100 | 177,336 |
| 03:59:42 pm | 896.1 | 100 | 177,236 |
| 03:59:42 pm | 895.8 | 100 | 177,136 |
Monthly variations
Annual change
| 2024 | +2.11% | ||
| 2023 | +21.73% | ||
| 2022 | +14.25% | ||
| 2021 | +30.72% | ||
| 2020 | +28.66% | ||
| 2019 | +0.53% | ||
| 2018 | -0.65% | ||
| 2017 | +2.42% | ||
| 2016 | -32.38% | ||
| 2015 | +32.33% | ||
| 2014 | +49.05% | ||
| 2013 | +60.89% | ||
| 2012 | +208.62% | ||
| 2011 | +68.84% | ||
| 2010 | +35.77% | ||
| 2009 | +31.70% | ||
| 2008 | -23.98% | ||
| 2007 | +20.33% | ||
| 2006 | +26.23% | ||
| 2005 | +72.64% | ||
| 2004 | -37.39% | ||
| 2003 | -20.53% | ||
| 2002 | -34.27% | ||
| 2001 | -20.15% | ||
| 2000 | +176.59% | ||
| 1999 | +72.88% | ||
| 1998 | -13.87% | ||
| 1997 | -46.90% | ||
| 1996 | +26.47% | ||
| 1995 | +325.00% | ||
| 1994 | -80.65% | ||
| 1993 | +29.17% | ||
| 1992 | -33.79% | ||
| 1991 | -14.20% |
- Stock Market
- Equities
- REGN Stock
- Quotes Regeneron Pharmaceuticals, Inc.
